Monoclonal antibodies produced to Aspergillus conidia detect small molecular weight galactofuranose-containing Aspergillus antigens in urine (animals, humans)
Detection of antigen is improved by processing urine through a column prior to testing.
With our monoclonal antibodies and patent-pending technology, we can detect fungal antigens in high amounts in urine using immobilized devices. Shown is a urine test showing fungal antigens (T = test, C = control) from a patient with confirmed fungal pneumonia.
Pearl Diagnostics is focused on development and commercialization of products to enable early detection and prevention of fungal infections.